Related Experiment Video
Updated: Jun 7, 2026

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations
Published on: February 2, 2024
Pain management in intellectually disabled children: Assessment, treatment, and translational research
Abraham J Valkenburg1, Monique van Dijk, Annelies de Klein
1Department of Pediatric Surgery and Pain Expertise Center, Erasmus University Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands. a.valkenburg@erasmusmc.nl
Insights
Validated pain assessment tools exist for children with intellectual disabilities. Future research should focus on tailoring pain treatment through pharmacokinetic studies and genotype-phenotype analysis to develop specific analgesic algorithms.
Area of Science:
- Medical Research
- Pediatrics
- Pain Management
Background:
- Pain assessment in intellectually disabled children remains a primary research focus.
- Existing observational pain scales vary in application and target populations.
- Intellectually disabled children often have comorbidities and experience differential pain treatment.
Purpose of the Study:
- To explore the integration of validated pain assessment and postoperative pain treatment in intellectually disabled children.
- To determine the feasibility of developing specific analgesic algorithms for this population.
Main Methods:
- Review of existing literature on pain assessment scales and treatment in intellectually disabled children.
- Exploration of research gaps in pharmacological understanding and genotype-phenotype associations.
- Identification of needs for future pharmacokinetic and pharmacodynamic studies.
Main Results:
- Numerous validated observational pain assessment tools are available for intellectually disabled children.
- Significant gaps exist in knowledge regarding drug interactions and pharmacological issues in this population.
- Potential for genotype-phenotype associations in Down syndrome related to pain offers promising research avenues.
Conclusions:
- Current pain assessment tools for intellectually disabled children are adequate.
- There is a critical need to shift focus towards tailoring pain treatment strategies.
- Pharmacokinetic/pharmacodynamic studies and genotype-phenotype research are essential for developing personalized analgesic algorithms.
Abstract:
The primary focus of pain research in intellectually disabled individuals is still on pain assessment. Several observational pain assessment scales are available, each with its own characteristics, its own target group and its own validated use. Observational studies report differences in the treatment of intra- and postoperative pain of intellectually disabled children and almost all children with intellectual disability have comorbidities that need to be addressed. The scope of research has started to broaden. In this review we aim to answer the question: Can we integrate validated ways of pain assessment and postoperative pain treatment in intellectually disabled children to develop specific analgesic algorithms? Regrettably there is little knowledge on possible interaction effects and other relevant pharmacological issues. Possible genotype-phenotype associations related to pain in children with Down syndrome have several promises as six possible candidate genes are located on chromosome 21. In conclusion, the pain assessment tools for intellectually disabled children are there. We should now focus on tailoring the pain treatment. To this aim we need to perform pharmacokinetic and pharmacodynamic studies of analgesics and obtain information about the genotype-phenotype relationships for pain. This can lead to the development of specific analgesic algorithms.
